Brigham & Women's Hospital (BWH)

Boston, Massachusetts 02115

0 studies enrolling now · 3 studies all time

What they study most

Castration-Resistant Prostate Cancer, Neoplasms, Triple-Negative Breast Cancer

Studies at this site

• Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566 — Completed
• A Study Of PF-06647263 In Patients With Advanced Solid Tumors — Stopped early
• Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed